This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (November 2023)
|
ARO-APOC3 is an apolipoprotein C-III antagonist and RNAi therapeutic investigated for dyslipidemia and familial chylomicronemia syndrome.[1][2]